Endocrine Disruption Screening Market Scope And Analysis

Report Code : TIPRE00025912
Category : Biotechnology

Status : Published
No. of Pages : 226

Buy Now

Endocrine Disruption Screening Market Scope and Analysis by 2028

Buy Now

Endocrine Disruption Screening Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 126.53 Million
Market Size by 2028	US$ 153.30 Million
Global CAGR (2021 - 2028)	2.8%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Assay Type In-Vitro and In-Vivo By Application Natural Materials and Synthetic Materials By Sources of Waste Incineration and Landfill Agricultural Runoff Industrial and Municipal Effluents Pulp Mill Effluents Consumer Products By Method Estrogen Receptor Transactivation Androgen Receptor Transactivation Androgen Receptor Modulation Estrogen Receptor-Alpha Binding Estrogen Receptor-Beta Binding Androgen Receptor Binding Steroidogenesis Aromatase Assay
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	CREATIVE BIOARRAY XENOMETRIX AG CHARLES RIVER EUROFINS SCIENTIFIC SMITHERS SGS SA JRF GLOBAL M RIEUX NUTRISCIENCES ALPHA ANALYTICAL

The report segments endocrine disruption screening market as follows

Endocrine Disruption Screening Market – by Assay Type

In-Vitro
In-Vivo

Endocrine Disruption Screening Market – by Application

Natural Materials
Synthetic Materials

Endocrine Disruption Screening Market – by Sources of Waste

Incineration and Landfill
Agricultural Runoff
Industrial and Municipal Effluents
Pulp Mill Effluents
Consumer Products
Others

Endocrine Disruption Screening Market – by Method

Estrogen Receptor (ER) Transactivation
Androgen Receptor (AR) Transactivation
Androgen Receptor (AR) Modulation
Estrogen Receptor-Alpha (ER-alpha) Binding
Estrogen Receptor Beta (ER-beta) Binding
Androgen Receptor (AR) Binding
Steroidogenesis
Aromatase Assay
Others

Endocrine Disruption Screening Market – by End User

Pharmaceutical and Biopharmaceutical Companies
Chemical Industry
Food Industry
Cosmetics and Household Product Companies

Endocrine Disruption Screening Market – by Geography

North America
- US
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South and Central America

Company Profiles

CREATIVE BIOARRAY
XENOMETRIX AG
CHARLES RIVER LABORATORIES, INC.
EUROFINS SCIENTIFIC Ltd.
SMITHERS
SGS SA
JRF GLOBAL
MéRIEUX NUTRISCIENCES
ALPHA ANALYTICAL INC.